Hypertension as a risk factor for diabetic neuropathy - A prospective study

被引:144
作者
Forrest, KYZ
Maser, RE
Pambianco, G
Becker, DJ
Orchard, TJ
机构
[1] UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT EPIDEMIOL, PITTSBURGH, PA USA
[2] UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA
[3] UNIV DELAWARE, DEPT MED TECHNOL, NEWARK, DE USA
关键词
D O I
10.2337/diabetes.46.4.665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathogeneses of diabetic neuropathy is still unclear. This study prospectively investigated the risk factors for distal symmetrical polyneuropathy (DSP) in a cohort of childhood-onset IDDM patients. Subjects from the Epidemiology of Diabetes Complications (EDC) Study were clinically examined at baseline and then biennially. DSP was diagnosed by a combination of clinical criteria, symptoms and signs (Diabetes Control and Complications Trial [DCCT] exam), and quantitative sensory threshold (QST). Among the 463 (70.4%) subjects who were free of DSP at baseline, 453 (97.8%) participated in at least one biennial reexamination during the first 6 years of follow-up and were included in the current analysis. A total of 68 (15.0%) subjects developed DSP in 6 years, giving a cumulative probability of 0.29. The Cox proportional hazards model shows that longer IDDM duration, hypertension, poor glycemic control, height, and smoking were all independent predictors of the incidence of DSP (all P < 0.0001, except for smoking for which P = 0.03). Hypertension showed the greatest impact on the development of DSP for individuals with either short or long IDDM duration. This study confirms some risk factors for DSP found in cross-sectional studies and suggests a strong relationship between hypertension and DSP. The results indicate that in addition to good glycemic control, avoidance of smoking and good blood pressure control may be helpful in preventing or delaying the onset of DSP in IDDM patients.
引用
收藏
页码:665 / 670
页数:6
相关论文
共 39 条
  • [1] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [2] AREZZO JC, 1993, QUANTITATIVE SENSORY, V2
  • [3] BUCOLO G, 1973, CLIN CHEM, V19, P476
  • [4] Christiansen J S, 1978, Diabetes Care, V1, P146, DOI 10.2337/diacare.1.3.146
  • [5] DCCT Res Grp, 1988, DIABETES, V37, P476
  • [6] *EARL TREATM DIAB, 1980, MAN OP, P18
  • [7] FOUNDS HW, 1996, 1 ANN M MOL MED SOC
  • [8] SENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - THE SAN-LUIS VALLEY DIABETES STUDY
    FRANKLIN, GM
    KAHN, LB
    BAXTER, J
    MARSHALL, JA
    HAMMAN, RF
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (04) : 633 - 643
  • [9] RISK-FACTORS FOR DISTAL SYMMETRICAL NEUROPATHY IN NIDDM - THE SAN-LUIS VALLEY DIABETES STUDY
    FRANKLIN, GM
    BAXTER, J
    SHETTERLY, SM
    HAMMAN, RF
    COHEN, JA
    [J]. DIABETES CARE, 1994, 17 (10) : 1172 - 1177
  • [10] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499